Efficacy of Biofeedback in Chronic back Pain: a Meta-Analysis

Sielski, Robert; Rief, Winfried; Glombiewski, Julia Anna

doi:10.1007/s12529-016-9572-9

Cited by 94 publications

(52 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Previous evidence suggests that there is an optimal range for RSA based on breathing rate and vagal input (19). Furthermore, most HRV intervention studies including biofeedback training with a slow controlled breathing rate or meditation (61) and HRV changes are measured throughout a longer duration with daily sessions for six weeks (22,24,62).…”

Section: Discussionmentioning

confidence: 99%

Targeting the Autonomic Nervous System Balance in Patients with Chronic Low Back Pain using Transcranial Alternating Current Stimulation: A Randomized, Crossover, Double-Blind, Placebo-Controlled Pilot Study

Prim

Ahn

Davila

et al. 2019

Preprint

View full text Add to dashboard Cite

BackgroundChronic low back pain (CLBP) is characterized by an alteration in pain processing by the central nervous system that may affect autonomic nervous system (ANS) balance. Heart rate variability (HRV) reflects the balance of parasympathetic and sympathetic ANS activation. In particular, respiratory sinus arrhythmia (RSA) solely reflects parasympathetic input and is reduced in CLBP patients. Yet, it remains unknown if non-invasive brain stimulation can alter ANS balance in CLBP patients.ObjectiveTo evaluate if non-invasive brain stimulation modulates the ANS, we analyzed HRV metrics collected in a previously published study of transcranial alternating current stimulation (tACS) for the modulation of CLBP through enhancing alpha oscillations. We hypothesized that tACS would increase RSA.MethodsA randomized, crossover, double-blind, sham-controlled pilot study was conducted to investigate the effects of 10Hz-tACS on metrics of ANS balance calculated from electrocardiogram (ECG). ECG data were collected for 2 minutes before and after 40 minutes of 10Hz-tACS or sham stimulation.ResultsThere were no significant changes in RSA or other frequency-domain HRV components from 10Hz-tACS. However, exploratory time-domain HRV analysis revealed a significant increase in the standard deviation of normal RR intervals (SDNN) for 10Hz-tACS relative to sham.Conclusion(s)Although tACS did not significantly increase RSA, we found in an exploratory analysis that tACS modulated an integrated HRV measure of both ANS branches. These findings support the further study of how the ANS and alpha oscillations interact and are modulated by tACS.

show abstract

Section: Discussionmentioning

confidence: 99%

Targeting the Autonomic Nervous System Balance in Patients with Chronic Low Back Pain using Transcranial Alternating Current Stimulation: A Randomized, Crossover, Double-Blind, Placebo-Controlled Pilot Study

Prim

Ahn

Davila

et al. 2019

Preprint

View full text Add to dashboard Cite

show abstract

“…Other techniques including mindfulness meditation‐based interventions , cognitive behavioral therapy , acceptance and commitment therapy , biofeedback , and distraction techniques (virtual reality) can be helpful in chronic pain patients, but there are no systematic reviews evaluating these treatment modalities in patients with cancer pain .…”

Section: Management Strategiesmentioning

confidence: 99%

Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain

Ulker

Fabbro

2019

The Oncologist

View full text Add to dashboard Cite

Introduction Nonmedical opioid use (NMOU) in patients with cancer is a term covering a spectrum of nonprescribed opioid use. The extent to which an individual uses opioids in a nonprescribed manner will influence propensity for adverse effects such as neurotoxicity, substance use disorder, overdose, and death. Objectives The objectives of this study were to (A) evaluate current literature regarding management of NMOU in patients with cancer‐related pain; (B) provide best practice recommendations based on evidence; and (C) integrate practices derived from the management of noncancer pain, where clinically appropriate or when the oncology literature is limited. Methods This study is a narrative review. Implications Although harm from NMOU was thought to be rare among oncology patients, about one in five patients with cancer is at risk of adverse outcomes including prolonged opioid use, high opioid doses, and increased health care utilization. The management of NMOU can be challenging because pain is a multidimensional experience encompassing physical, psychological, and spiritual domains. An interdisciplinary team approach is most effective, and management strategies may include (A) education of patients and families; (B) harm reduction, including opioid switching, decreasing the overall daily dose, avoiding concurrent sedative use, and using adjuvant medications for their opioid‐sparing potential; (C) managing psychological and spiritual distress with an interdisciplinary team and techniques such as brief motivational interviewing; and (D) risk mitigation by pill counts, frequent clinic visits, and accessing statewide prescription drug monitoring plans. Conclusion Although many of the management strategies for NMOU in patients with cancer‐related pain are modeled on those for chronic non–cancer‐related pain, there is emerging evidence that education and harm‐reduction initiatives specifically for cancer‐related pain are effective. Implications for Practice Nonmedical opioid use (NMOU) in patients with cancer is a term covering a broad spectrum of nonprescribed opioid use. The extent to which an individual uses opioids in a nonprescribed manner will influence propensity for adverse effects such as neurotoxicity, substance use disorder, overdose, and death. This review evaluates the evidence for best practices in oncology and addresses limitations in the literature with supplemental evidence from noncancer chronic pain. Management recommendations for NMOU are provided, based on a combination of literature‐based evidence and best clinical practice. Effective management of NMOU in oncology has the potential to improve quality of life, decrease health utilization, and improve survival.

show abstract

“…Показники поширеності вертеброневрологічної патології мають тенденцію до зростання, особливо щодо випадків дорсалгій у молодому віці, частих ускладнень процесу, збільшення кількості днів непрацездатності у зв'язку із загостренням захворювання [3,4].…”

Section: фізична терапія та ерготерапіяunclassified

“…До сучасних методів лікування спрямованого на функціональне відновлення у хворих на патологію хребта належать як консервативні, так і оперативні. Понад 97 % пацієнтів в даний час лікуються консервативно і лише близько 3 % потребують оперативних втручань [4,6]. Частота післяопераційного больового синдрому серед прооперованих складає 25-30 %, а 7-8 % з них, на жаль, потребують повторних втручань [9].…”

Section: фізична терапія та ерготерапіяunclassified

“…Недостатня результативність відновного лікування і традиційної системи профілактичних заходів змушують вести пошук більш ефективних рішень в реалізації фізичної реабілітації при лікуванні хворих з вертеброгенною патологією. Патоморфологічну основу остеохондрозу складає комплекс ішемічних, дегенеративних і репаративних змін в хрящі, кістки і навколишніх м'яких тканинах [1,4,6,7]. Дані структурнофункціональні зміни визначаються характером і виразністю запальних і проліферативних процесів в зоні ураження.…”

Section: фізична терапія та ерготерапіяunclassified

See 1 more Smart Citation

The Effectiveness of Using Platelet–Rich Plasma in the Treatment of Patients with Spinal Osteochondrosis

Badyin¹

2019

Ukr. ž. med. bìol. sportu

View full text Add to dashboard Cite

ДУ «Інститут медицини транспорту МОЗ України», Одеса, Україна badyin2035@i.ua УДК 616.71-018.3-002-08 ЭФФЕКТИВНОСТЬ ПРИМЕНЕНИЯ ПЛАЗМЫ, ОБОГАЩЕННОЙ ТРОМБОЦИТАМИ, В ЛЕЧЕНИИ БОЛЬНЫХ ОСТЕОХОНДРОЗОМ ПОЗВОНОЧНИКА Бадьин И. Ю. Целью исследования была оценка клинической эффективности применения плазмы обогащенной тромбоцитами для функционального восстановления пациентов с вертеброневрологической патологией.

show abstract

Efficacy of Biofeedback in Chronic back Pain: a Meta-Analysis

Abstract: It is concluded that biofeedback treatment can lead to improvements on various pain-related outcomes in the short and long terms, both as a standalone and as an adjunctive intervention.

Cited by 94 publications

References 61 publications

Targeting the Autonomic Nervous System Balance in Patients with Chronic Low Back Pain using Transcranial Alternating Current Stimulation: A Randomized, Crossover, Double-Blind, Placebo-Controlled Pilot Study

Targeting the Autonomic Nervous System Balance in Patients with Chronic Low Back Pain using Transcranial Alternating Current Stimulation: A Randomized, Crossover, Double-Blind, Placebo-Controlled Pilot Study

Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain

The Effectiveness of Using Platelet–Rich Plasma in the Treatment of Patients with Spinal Osteochondrosis

Contact Info

Product

Resources

About